Breakthrough mouse model of celiac disease could lead to new treatments
University of Chicago researchers have developed the first truly accurate mouse model of celiac disease—a scientific breakthrough more than 20 years in the making.
Hepatitis C cure means many liver failure patients have a better chance at transplantation and recovery
Medications that cure hepatitis C have had a positive domino effect on several patient groups waiting for liver transplants, including those with alcohol-associated liver disease.
Cancer clinicians and scientists transition their talents to tackle the COVID-19 pandemic
Researchers from the University of Chicago Medicine Comprehensive Cancer Center are leading large-scale efforts to diagnose and treat COVID-19 to protect the health of their patients and everyone.
